{"id": "1385647384206749697", "creation": 1619199055.0, "user_id": "1233901069366771712", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "Is There Enough Oxygen in Ocugen COVID-19 Vaccine Stock? This Analyst This So\ud83e\udd14\n\nOne just needs to look at $AZN US experience to understand the difficulties ahead for $OCGN in commercializing #Covaxin #COVID19 #vaccine from India's #Bharat Biotech.\n\nhttps://t.co/nMxdDhUUwP", "first_save": 1634559108.199414, "hashtags": ["#COVAXIN", "#COVID19", "#VACCINE", "#BHARAT"]}